This acquisition will add foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson's disease
Attachment

Lundbeck announced on 16 March 2018 that it will acquire Prexton Therapeutics for up to EUR 905 million.

Full press release

Find an actor

ILMAC Lausanne 201803.10.2018

ILMAC Lausanne is the new platform for the chemical & life sciences community. The event will take place on 3 and 4...

Alcon arrive à Genève

Alcon quitte Novartis et choisi le canton de Genève pour s'installer avec une équipe de 700 personnes.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn